Enhanced Maturation of 3D Bioprinted Skeletal Muscle Tissue Constructs Encapsulating Soluble Factor‐Releasing Microparticles

Author:

de Barros Natan Roberto1ORCID,Darabi Mohammad Ali1,Ma Xin2,Diltemiz Sibel Emir3,Ermis Menekse1,Hassani Najafabadi Alireza1,Nadine Sara14,Banton Ethan A.2,Mandal Kalpana1,Abbasgholizadeh Reza1,Falcone Natashya1,Mano João F.4,Nasiri Rohollah1,Herculano Rondinelli Donizetti1,Zhu Yangzhi1,Ostrovidov Serge5,Lee Junmin16,Kim Han‐Jun178,Hosseini Vahid1,Dokmeci Mehmet R.1,Ahadian Samad9,Khademhosseini Ali125910ORCID

Affiliation:

1. Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90064 USA

2. Center for Minimally Invasive Therapeutics (C‐MIT) University of California‐Los Angeles Los Angeles CA 90095 USA

3. Department of Chemistry Eskisehir Technical University Eskisehir 26470 Turkey

4. CICECO ‐ Aveiro Institute of Materials, Department of Chemistry University of Aveiro, Campus Universitário de Santiago Aveiro 3810‐193 Portugal

5. Department of Radiological Sciences University of California‐Los Angeles Los Angeles CA 90095 USA

6. Department of Materials Science and Engineering Pohang University of Science and Technology (POSTECH) Pohang 790‐784 Republic of Korea

7. College of Pharmacy Korea University Sejong 30019 Republic of Korea

8. Vellore Institute of Technology (VIT) Vellore 632014 India

9. Department of Bioengineering University of California‐Los Angeles Los Angeles CA 90095 USA

10. Department of Chemical and Biomolecular Engineering University of California‐Los Angeles Los Angeles CA 90095 USA

Abstract

AbstractSeveral microfabrication technologies have been used to engineer native‐like skeletal muscle tissues. However, the successful development of muscle remains a significant challenge in the tissue engineering field. Muscle tissue engineering aims to combine muscle precursor cells aligned within a highly organized 3D structure and biological factors crucial to support cell differentiation and maturation into functional myotubes and myofibers. In this study, the use of 3D bioprinting is proposed for the fabrication of muscle tissues using gelatin methacryloyl (GelMA) incorporating sustained insulin‐like growth factor‐1 (IGF‐1)‐releasing microparticles and myoblast cells. This study hypothesizes that functional and mature myotubes will be obtained more efficiently using a bioink that can release IGF‐1 sustainably for in vitro muscle engineering. Synthesized microfluidic‐assisted polymeric microparticles demonstrate successful adsorption of IGF‐1 and sustained release of IGF‐1 at physiological pH for at least 21 days. Incorporating the IGF‐1‐releasing microparticles in the GelMA bioink assisted in promoting the alignment of myoblasts and differentiation into myotubes. Furthermore, the myotubes show spontaneous contraction in the muscle constructs bioprinted with IGF‐1‐releasing bioink. The proposed bioprinting strategy aims to improve the development of new therapies applied to the regeneration and maturation of muscle tissues.

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering,Biotechnology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3